Kitano K, Ichimori Y, Sawada H, Iwasa S, Sasai S, Tsukamoto K
Cytotechnology. 2012; 5(Suppl 2):53-74.
PMID: 22359046
DOI: 10.1007/BF00573880.
Shintani Y, Iwamoto K, Kitano K
Cytotechnology. 2012; 18(3):173-81.
PMID: 22358743
DOI: 10.1007/BF00767765.
Beerli R, Rader C
MAbs. 2010; 2(4):365-78.
PMID: 20505349
PMC: 3180084.
DOI: 10.4161/mabs.12187.
Yoshida S, Veit B, Mansfield L, Gershwin M
Clin Rev Allergy. 1994; 12(2):125-49.
PMID: 7954186
DOI: 10.1007/BF02802351.
Gigliotti F, Insel R
J Clin Invest. 1982; 70(6):1306-9.
PMID: 7174795
PMC: 370348.
DOI: 10.1172/jci110730.
Loss of secretion in mouse-human hybrids need not be due to the loss of a structural gene.
Raison R, Walker K, Halnan C, Briscoe D, Basten A
J Exp Med. 1982; 156(5):1380-9.
PMID: 7130902
PMC: 2186836.
DOI: 10.1084/jem.156.5.1380.
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
Lane H, Shelhamer J, Mostowski H, Fauci A
J Exp Med. 1982; 155(1):333-8.
PMID: 6976416
PMC: 2186568.
DOI: 10.1084/jem.155.1.333.
Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas.
Galfre G, Milstein C
Immunology. 1982; 45(1):125-8.
PMID: 6799391
PMC: 1555168.
UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
Glassy M, Handley H, Hagiwara H, Royston I
Proc Natl Acad Sci U S A. 1983; 80(20):6327-31.
PMID: 6604917
PMC: 394290.
DOI: 10.1073/pnas.80.20.6327.
Generation of human monoclonal antibodies reactive with cellular antigens.
Cote R, MORRISSEY D, Houghton A, Beattie Jr E, Oettgen H, Old L
Proc Natl Acad Sci U S A. 1983; 80(7):2026-30.
PMID: 6572959
PMC: 393745.
DOI: 10.1073/pnas.80.7.2026.
Human monoclonal antibodies: methods of production and some aspects of their application in oncology.
Olsson L
Med Oncol Tumor Pharmacother. 1984; 1(4):235-46.
PMID: 6400038
DOI: 10.1007/BF02934529.
Human hybridomas from patients with malignant disease.
Sikora K, Alderson T, Ellis J, Phillips J, Watson J
Br J Cancer. 1983; 47(1):135-45.
PMID: 6336943
PMC: 2011244.
DOI: 10.1038/bjc.1983.16.
Chemotherapy of influenza and herpes virus infections.
Oxford J
J R Coll Physicians Lond. 1981; 15(4):218-9, 222-6.
PMID: 6275080
PMC: 5377705.
Hybridomas: a new dimension in biological analyses.
Kennett R
In Vitro. 1981; 17(12):1036-50.
PMID: 6172364
DOI: 10.1007/BF02618601.
Generating human monoclonal antibodies.
Neville A, Edwards P, OHare M
Med Oncol Tumor Pharmacother. 1984; 1(2):73-6.
PMID: 6100557
DOI: 10.1007/BF02934977.
Human monoclonal antibodies.
Cole S, Campling B, Atlaw T, Kozbor D, Roder J
Mol Cell Biochem. 1984; 62(2):109-20.
PMID: 6087121
DOI: 10.1007/BF00223301.
The application of hybridoma technology to the study of bovine immunoglobulins.
Goldsby R, Srikumaran S, Arulanandam A, Hague B, Ponce de Leon F, Sevoian M
Vet Immunol Immunopathol. 1987; 17(1-4):25-35.
PMID: 3501632
PMC: 7126093.
DOI: 10.1016/0165-2427(87)90124-3.
Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
Thompson K, MELAMED M, Eagle K, Gorick B, Gibson T, Holburn A
Immunology. 1986; 58(1):157-60.
PMID: 3011653
PMC: 1452628.
Changes in lectin binding pattern of gonads of developing mice.
Kanai Y, Kawakami H, Kurohmaru M, Hayashi Y, Nishida T, Hirano H
Histochemistry. 1989; 92(1):37-42.
PMID: 2768001
DOI: 10.1007/BF00495013.
Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski C, Chou D, JUNGALWALA F
J Clin Invest. 1989; 84(1):280-7.
PMID: 2738153
PMC: 303980.
DOI: 10.1172/JCI114152.